Mesenchymal stem cells for graft vs. host disease (CHU University Hospital Liege)
This trial aims to investigate the potential of mesenchymal stem cells (MSCs) in treating patients with steroid-refractory grade II-IV acute graft vs host disease (GVHD), poor graft function, or low or falling donor T-cell chimerism after allogeneic hematopoietic cell transplantation (HCT).
Read More
The cells were not characterized by the sponsor.
Read More
Product Information for
Mesenchymal stem cells for graft vs. host disease (CHU University Hospital Liege)